| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4293038
Max Phase: Preclinical
Molecular Formula: C27H24ClN3O2
Molecular Weight: 457.96
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1cc2nc(C(=O)N3CCOCC3)cc(-c3ccccc3Cl)c2c(C)c1-c1ccncc1
Standard InChI: InChI=1S/C27H24ClN3O2/c1-17-15-23-26(18(2)25(17)19-7-9-29-10-8-19)21(20-5-3-4-6-22(20)28)16-24(30-23)27(32)31-11-13-33-14-12-31/h3-10,15-16H,11-14H2,1-2H3
Standard InChI Key: VDMUEVOMMWQMDX-UHFFFAOYSA-N
Associated Targets(non-human)
Long-chain-fatty-acid--AMP ligase FadD32 36 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 457.96 | Molecular Weight (Monoisotopic): 457.1557 | AlogP: 5.71 | #Rotatable Bonds: 3 |
| Polar Surface Area: 55.32 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
| #RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: 5.05 | CX LogP: 5.30 | CX LogD: 5.30 |
| Aromatic Rings: 4 | Heavy Atoms: 33 | QED Weighted: 0.40 | Np Likeness Score: -1.17 |
References
| 1. Fang C, Lee KK, Nietupski R, Bates RH, Fernandez-Menendez R, Lopez-Roman EM, Guijarro-Lopez L, Yin Y, Peng Z, Gomez JE, Fisher S, Barros-Aguirre D, Hubbard BK, Serrano-Wu MH, Hung DT.. (2018) Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors., 28 (22): [PMID:30316633] [10.1016/j.bmcl.2018.09.037] |
Source
Source(1):